The Hidden Link Between Diabetes and Cognitive Decline As the global prevalence of diabetes continues to rise, so does the concern about its impact on cognitive function. Diabetic patients are not only at a higher risk of developing cardiovascular diseases, neuropathy, and retinopathy but also face a significant challenge in diagnosing and managing dementia and Alzheimer’s disease..
Introduction A recent analysis published in _JAMA Internal Medicine_ has highlighted a significant issue with the distribution of the Alzheimer's medication lecanemab (Leqembi), leading to substan..
UConn Health is now offering a groundbreaking treatment for individuals with mild signs of dementia due to Alzheimer's disease. This new drug, lecanemab, has shown significant promise in clinical trials by slowing the progression of the disease..
Stay up-to-date with our latest news, articles, and exclusive offers. Join our community and never miss an important update!